PIGT

protein-coding

phosphatidylinositol glycan anchor biosynthesis class T, the group of Phosphatidylinositol glycan anchor biosynthesis|Glycosylphosphatidylinositol transamidase complex|MicroRNA protein coding host genes

Gene summary

This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This protein is an essential component of the multisubunit enzyme, GPI transamidase. GPI transamidase mediates GPI anchoring in the endoplasmic reticulum, by catalyzing the transfer of fully assembled GPI units to proteins. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]

MANE transcript

NM_015937.6

Inheritance

AR

ClinVar variants

P:36U:194B:104

Top phenotype

Multiple congenital anomalies-hypotonia-seizures syndrome 3

gnomAD constraint

pLI —, LoF o/e 0.65

Max pathogenic AF

—

Genomic locus

chr20:45,416,084-45,456,934

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~40.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

multiple congenital anomalies-hypotonia-seizures syndrome 3STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014165

Submitter: PanelApp Australia

multiple congenital anomalies-hypotonia-seizures syndrome 3STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014165

Submitter: Labcorp Genetics (formerly Invitae)

multiple congenital anomalies-hypotonia-seizures syndrome 3STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014165

Submitter: Ambry Genetics

multiple congenital anomalies-hypotonia-seizures syndrome 3DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014165

Submitter: G2P

multiple congenital anomalies-hypotonia-seizures syndrome 3SUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014165

Submitter: Orphanet

multiple congenital anomalies-hypotonia-seizures syndrome 3DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014165

Submitter: ClinGen

*PIGT* was first reported in relation to autosomal recessive multiple congenital anomalies-hypotonia-seizures syndrome 3 in 2013 (Kvarnung et al., PMID: 23636107). 12 variants (missense, nonsense, frameshift, and canonical splice) that have been reported in 9 probands in 7 publications (PMIDs: 23636107, 24906948, 25943031, 28728837, 30976099, 34162574, 39417547) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function. This gene-disease relationship is also supported by a zebrafish model and flow cytometry studies on patient cells (PMIDs: 23636107, 25943031, 28728837). In summary, there is definitive evidence supporting the relationship between *PIGT* and autosomal recessive multiple congenital anomalies-hypotonia-seizures syndrome 3. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date August 7, 2025 (SOP Version 11).

Clinical Genomic Database (CGD)

Multiple congenital anomalies-hypotonia-seizures syndrome 3AR

Manifestation: Craniofacial; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 23636107; 24906948; 25943031; 28728837Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to PIGT variants in ClinVar

11 Conditions Cataloged
Multiple congenital anomalies-hypotonia-seizures syndrome 3Total: 245
not providedTotal: 142
Inborn genetic diseasesTotal: 102
not specifiedTotal: 38
PIGT-related disorderTotal: 21
Paroxysmal nocturnal hemoglobinuria 2Total: 11
Neurodevelopmental delayTotal: 2
High myopiaTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_015937.6. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
86
clinvar
1
clinvar
89
missense
11
clinvar
185
clinvar
16
clinvar
1
clinvar
213
nonsense
4
clinvar
1
clinvar
1
clinvar
6
start loss
0
frameshift
7
clinvar
11
clinvar
5
clinvar
23
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
1
clinvar
3
Total12241941022334

Highest pathogenic variant AF is 0.0001134674

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 127 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_015937.6RefSeqNP_057021.212MANE Select
ENST00000279036.12EnsemblENSP00000279036.612MANE Select
NM_001184728.3RefSeqNP_001171657.111Standard
NM_001184729.3RefSeqNP_001171658.111Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
pigtDanio rerio

Structure: whole organism

Quality: shortened

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human)
  • Attachment of GPI anchor to uPAR
  • Post-translational modification: synthesis of GPI-anchored proteins
  • Post-translational protein modification
  • Metabolism of proteins

Biological Process

  • attachment of GPI anchor to protein
  • neuron differentiation
  • neuron apoptotic process

Molecular Function

  • GPI-anchor transamidase activity
  • protein binding

Cellular Component

  • endoplasmic reticulum membrane
  • membrane
  • integral component of endoplasmic reticulum membrane
  • cytoplasmic vesicle
  • GPI-anchor transamidase complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000279036
Coding exons
12
Length
10168
Individuals with no LoFs
125641
Homozygous LoFs
0
Heterozygous LoFs
107
Defined
125748
p
0.000426
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.2773263400.9580.00002003660
Missense (PolyPhen)145158.520.91471622
Synonymous-1.251691501.130.000008701234
Loss of Function1.781929.40.6460.00000158306

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000250.00025rare
Latino/Admixed American0.000230.00023rare
Ashkenazi Jewish00.0absent
East Asian0.00150.0014notable
Finnish0.000280.00028rare
European (Non-Finnish)0.000410.00040rare
South Asian0.000460.00046rare
Other0.000490.00049rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Component of the GPI transamidase complex. Essential for transfer of GPI to proteins, particularly for formation of carbonyl intermediates. {ECO:0000269|PubMed:11483512}.;
Disease
DISEASE: Multiple congenital anomalies-hypotonia-seizures syndrome 3 (MCAHS3) [MIM:615398]: An autosomal recessive syndrome characterized by distinct facial features, intellectual disability, hypotonia and seizures, in combination with abnormal skeletal, endocrine, and ophthalmologic findings including impaired vision, as well as abnormal motility of the eyes. {ECO:0000269|PubMed:23636107}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Paroxysmal nocturnal hemoglobinuria 2 (PNH2) [MIM:615399]: A disorder characterized by hemolytic anemia with hemoglobinuria, thromboses in large vessels, and a deficiency in hematopoiesis. Red blood cell breakdown with release of hemoglobin into the urine is manifested most prominently by dark-colored urine in the morning. {ECO:0000269|PubMed:23733340}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.114

Intolerance Scores

LoFtool
0.941
RVIS EVS
-0.15
RVIS percentile EVS
42.23

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
S
Essential (gene trap)
H
Indispensability pred.
E
Indispensability score
0.832

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.